Wells Fargo’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $117M | Sell |
302,259
-58,934
| -16% | -$21.9M | 0.02% | 608 |
|
|
2026
Q1 | $106M | Buy |
361,193
+2,048
| +0.6% | +$673K | 0.02% | 604 |
|
|
2025
Q4 | $126M | Sell |
359,145
-41,435
| -10% | -$14M | 0.02% | 538 |
|
|
2025
Q3 | $129M | Buy |
400,580
+37,232
| +10% | +$11.6M | 0.02% | 517 |
|
|
2025
Q2 | $141M | Buy |
363,348
+20,619
| +6% | +$8.29M | 0.03% | 438 |
|
|
2025
Q1 | $149M | Buy |
342,729
+28,684
| +9% | +$11.5M | 0.03% | 386 |
|
|
2024
Q4 | $116M | Sell |
314,045
-66,325
| -17% | -$27.8M | 0.03% | 490 |
|
|
2024
Q3 | $198M | Buy |
380,370
+10,290
| +3% | +$5.5M | 0.04% | 332 |
|
|
2024
Q2 | $201M | Buy |
370,080
+10,303
| +3% | +$5.45M | 0.05% | 306 |
|
|
2024
Q1 | $187M | Buy |
359,777
+15,311
| +4% | +$7.61M | 0.04% | 317 |
|
|
2023
Q4 | $162M | Buy |
344,466
+14,762
| +4% | +$6.83M | 0.04% | 339 |
|
|
2023
Q3 | $144M | Sell |
329,704
-43,618
| -12% | -$19.8M | 0.04% | 331 |
|
|
2023
Q2 | $166M | Buy |
373,322
+7,181
| +2% | +$3.31M | 0.05% | 312 |
|
|
2023
Q1 | $168M | Sell |
366,141
-3,445
| -0.9% | -$1.64M | 0.05% | 311 |
|
|
2022
Q4 | $190M | Sell |
369,586
-8,035
| -2% | -$4.08M | 0.06% | 281 |
|
|
2022
Q3 | $172M | Buy |
377,621
+1,271
| +0.3% | +$608K | 0.06% | 289 |
|
|
2022
Q2 | $182M | Sell |
376,350
-75,541
| -17% | -$37.4M | 0.06% | 289 |
|
|
2022
Q1 | $222M | Buy |
451,891
+14,518
| +3% | +$6.64M | 0.06% | 278 |
|
|
2021
Q4 | $203M | Sell |
437,373
-171,532
| -28% | -$72.2M | 0.05% | 296 |
|
|
2021
Q3 | $227M | Sell |
608,905
-41,066
| -6% | -$15.6M | 0.05% | 366 |
|
|
2021
Q2 | $248M | Sell |
649,971
-63,299
| -9% | -$24.2M | 0.05% | 337 |
|
|
2021
Q1 | $256M | Sell |
713,270
-88,759
| -11% | -$28.5M | 0.06% | 329 |
|
|
2020
Q4 | $258M | Buy |
802,029
+56,217
| +8% | +$17.3M | 0.06% | 302 |
|
|
2020
Q3 | $200M | Sell |
745,812
-100,643
| -12% | -$27.1M | 0.06% | 333 |
|
|
2020
Q2 | $223M | Buy |
846,455
+37,259
| +5% | +$9.94M | 0.06% | 284 |
|
|
2020
Q1 | $184M | Sell |
809,196
-8,552
| -1% | -$2.33M | 0.06% | 287 |
|
|
2019
Q4 | $247M | Sell |
817,748
-179,609
| -18% | -$49.4M | 0.07% | 288 |
|
|
2019
Q3 | $239M | Buy |
997,357
+41,287
| +4% | +$11.3M | 0.07% | 287 |
|
|
2019
Q2 | $270M | Buy |
956,070
+204,283
| +27% | +$55.8M | 0.08% | 247 |
|
|
2019
Q1 | $216M | Buy |
751,787
+17,814
| +2% | +$5.15M | 0.06% | 300 |
|
|
2018
Q4 | $193M | Buy |
733,973
+2,381
| +0.3% | +$655K | 0.06% | 294 |
|
|
2018
Q3 | $200M | Sell |
731,592
-14,894
| -2% | -$3.87M | 0.06% | 339 |
|
|
2018
Q2 | $178M | Sell |
746,486
-113,902
| -13% | -$26.4M | 0.05% | 364 |
|
|
2018
Q1 | $189M | Sell |
860,388
-299,697
| -26% | -$70.4M | 0.06% | 342 |
|
|
2017
Q4 | $261M | Buy |
1,160,085
+314,451
| +37% | +$67M | 0.08% | 276 |
|
|
2017
Q3 | $161M | Buy |
845,634
+158,807
| +23% | +$30.2M | 0.05% | 392 |
|
|
2017
Q2 | $129M | Sell |
686,827
-143,799
| -17% | -$25.8M | 0.04% | 454 |
|
|
2017
Q1 | $137M | Buy |
830,626
+247,871
| +43% | +$39.4M | 0.04% | 424 |
|
|
2016
Q4 | $83.8M | Sell |
582,755
-35,489
| -6% | -$4.75M | 0.03% | 579 |
|
|
2016
Q3 | $77.5M | Sell |
618,244
-55,080
| -8% | -$7.11M | 0.03% | 600 |
|
|
2016
Q2 | $88.4M | Buy |
673,324
+47,474
| +8% | +$6.5M | 0.03% | 520 |
|
|
2016
Q1 | $87M | Sell |
625,850
-22,061
| -3% | -$2.95M | 0.03% | 514 |
|
|
2015
Q4 | $90.3M | Buy |
647,911
+67,831
| +12% | +$9.34M | 0.04% | 498 |
|
|
2015
Q3 | $81.2M | Sell |
580,080
-62,585
| -10% | -$9.41M | 0.03% | 538 |
|
|
2015
Q2 | $105M | Sell |
642,665
-16,082
| -2% | -$2.57M | 0.04% | 471 |
|
|
2015
Q1 | $102M | Buy |
658,747
+140,893
| +27% | +$20.1M | 0.04% | 469 |
|
|
2014
Q4 | $65.1M | Buy |
517,854
+8,385
| +2% | +$1.04M | 0.03% | 631 |
|
|
2014
Q3 | $60.9M | Sell |
509,469
-14,431
| -3% | -$1.66M | 0.03% | 649 |
|
|
2014
Q2 | $56.4M | Sell |
523,900
-5,223
| -1% | -$538K | 0.02% | 723 |
|
|
2014
Q1 | $52.7M | Buy |
529,123
+9,844
| +2% | +$890K | 0.02% | 738 |
|
|
2013
Q4 | $48M | Buy |
519,279
+3,560
| +0.7% | +$316K | 0.02% | 761 |
|
|
2013
Q3 | $43.1M | Buy |
515,719
+18,553
| +4% | +$1.59M | 0.02% | 758 |
|
|
2013
Q2 | $40.7M | Buy |
+497,166
| New | +$37.2M | 0.02% | 727 |
|
Other funds holding ELV
Wells Fargo's ELV Position: Q2 2026 in Review
Wells Fargo reduced its Elevance Health (ELV) stake by 16% in Q2 2026, selling an estimated $21.9M and leaving 302,259 shares worth $117M. The position accounts for 0.02% of the portfolio, ranked #608.
Wells Fargo first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $270M in Q2 2019. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Wells Fargo held 302,259 shares of Elevance Health worth $117M as of Q2 2026.
- Wells Fargo sold 58,934 Elevance Health shares in Q2 2026, an estimated $21.9M.
- Elevance Health made up 0.02% of Wells Fargo's portfolio in Q2 2026, its #608 holding.
- Wells Fargo first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
- Wells Fargo's Elevance Health position peaked at $270M in Q2 2019.
- 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.